Toronto Dominion Bank
BPMC

Toronto Dominion Bank’s Blueprint Medicines BPMC Stock Holding History

Toronto Dominion Bank’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-29,100
Closed -$3.12M – 1469
2021
Q4 		$3.12M Buy
+29,100
New +$3.04M ﹤0.01% 726
2021
Q2 		– Sell
-24
Closed -$2K – 1381
2021
Q1 		$2K Buy
+24
New +$2.4K ﹤0.01% 1377
2020
Q2 		– Sell
-1
Closed – – 1247
2020
Q1 		$0 Hold
1
– – ﹤0.01% 1254
2019
Q4 		$0 Buy
+1
New +$75 ﹤0.01% 1362

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Toronto Dominion Bank's BPMC Position: Q1 2022 in Review

Toronto Dominion Bank sold out of Blueprint Medicines (BPMC) in Q1 2022, closing a stake of 29,100 shares — an estimated $3.12M sold.

Toronto Dominion Bank first reported a position in BPMC in Q4 2019 and held it in 4 quarters. The position peaked at $3.12M in Q4 2021. 248 funds tracked by Wall St. Rank hold BPMC as of Q1 2022.

  • Toronto Dominion Bank reported no remaining Blueprint Medicines position as of Q1 2022 after selling out during the quarter.
  • Toronto Dominion Bank sold 29,100 Blueprint Medicines shares in Q1 2022, an estimated $3.12M.
  • Toronto Dominion Bank first reported a position in Blueprint Medicines in Q4 2019 and held it in 4 quarters.
  • Toronto Dominion Bank's Blueprint Medicines position peaked at $3.12M in Q4 2021.
  • 248 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2022.

Based on Toronto Dominion Bank's 13F filing for Q1 2022, filed 9 May 2022.